Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations
- 14 March 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Amino Acids
- Vol. 35 (4), 739-752
- https://doi.org/10.1007/s00726-008-0055-4
Abstract
Here we summarized what is known at the present about function, structure and effect of mutations in the human prolidase. Among the peptidases, prolidase is the only metalloenzyme that cleaves the iminodipeptides containing a proline or hydroxyproline residue at the C-terminal end. It is relevant in the latest stage of protein catabolism, particularly of those molecules rich in imino acids such as collagens, thus being involved in matrix remodelling. Beside its intracellular functions, prolidase has an antitoxic effect against some organophosphorus molecules, can be used in dietary industry as bitterness reducing agent and recently has been used as target enzyme for specific melanoma prodrug activation. Recombinant human prolidase was produced in prokaryotic and eukaryotic hosts with biochemical properties similar to the endogenous enzyme and represents a valid tool both to better understand the structure and biological function of the enzyme and to develop an enzyme replacement therapy for the prolidase deficiency (PD). Prolidase deficiency is a rare recessive disorder caused by mutations in the prolidase gene and characterized by severe skin lesions. Single amino acid substitutions, exon splicing, deletions and a duplication were described as causative for the disease and are mainly located at highly conserved amino acids in the sequence of prolidase from different species. The pathophysiology of PD is still poorly understood; we offer here a review of the molecular mechanisms so far hypothesized.Keywords
This publication has 82 references indexed in Scilit:
- Characterization of the dinuclear metal center ofPyrococcus furiosusprolidase by analysis of targeted mutantsFEBS Letters, 2005
- Mutation analysis of five new patients affected by prolidase deficiency: the lack of enzyme activity causes necrosis-like cell death in cultured fibroblastsHuman Genetics, 2002
- OrlistatDrugs, 1999
- Recombinant proteins for therapyTrends in Pharmacological Sciences, 1996
- Prolidase deficiency: A multisystemic hereditary disorderJournal of the American Academy of Dermatology, 1993
- Structural and immunological evidence for the identity of prolyl aminopeptidase with leucyl aminopeptidaseBiochemical and Biophysical Research Communications, 1991
- Peptiduria presumably caused by aminopeptidase‐P deficiency. A new inborn error of metabolismJournal of Inherited Metabolic Disease, 1988
- Presence in human cells and tissues of two prolidases and their alteration in prolidase deficiencyJournal of Inherited Metabolic Disease, 1985
- Activation and Inhibition of Cerebral ProlidaseJournal of Neurochemistry, 1980
- Iminopeptiduria, skin ulcerations, and edema in a boy with prolidase deficiencyThe Journal of Pediatrics, 1977